Solara Active Pharma Sciences Limited (NSE:SOLARAPP1)
India · Delayed Price · Currency is INR 420.00
+5.30 (1.28%)
At close: Oct 16, 2025
NSE:SOLARAPP1 Revenue
Solara Active Pharma Sciences had revenue of 3.19 billion INR in the quarter ending June 30, 2025, a decrease of -12.20%. This brings the company's revenue in the last twelve months to 12.39 billion, down -4.67% year-over-year. In the fiscal year ending March 31, 2025, Solara Active Pharma Sciences had annual revenue of 12.84 billion, down -0.40%.
Revenue (ttm)
12.39B
Revenue Growth
-4.67%
P/S Ratio
2.32
Revenue / Employee
6.98M
Employees
1,775
Market Cap
28.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.84B | -51.60M | -0.40% |
| Mar 31, 2024 | 12.89B | -1.55B | -10.73% |
| Mar 31, 2023 | 14.44B | 1.75B | 13.83% |
| Mar 31, 2022 | 12.68B | -3.49B | -21.56% |
| Mar 31, 2021 | 16.17B | 2.95B | 22.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| Life Insurance Corporation of India | 9,038.65B |
| State Bank of India | 3,503.84B |
| HDFC Bank | 2,736.06B |
| Larsen & Toubro | 2,688.02B |
| Tata Consultancy Services | 2,576.88B |
| ICICI Bank | 2,054.85B |
| Bharti Airtel | 1,839.41B |